ArthroCare RazorVac System Will Drive 10% Arthroscopy Growth In 2002
This article was originally published in The Gray Sheet
ArthoCare plans to launch the RazorVac arthroscopy wand for use with its Coblation technology-based radiofrequency arthroscopic surgery system in knee procedures by the first quarter of 2002
You may also be interested in...
Expanded FDA clearance for the firm's Coblation technology-based radio frequency arthroscopic surgery system includes indications for articular cartilage debridement, ACL/PCL repair, subacromial decompression, meniscectomy and chondroplasty. The system currently is indicated for soft tissue resection, ablation, coagulation and hemostasis in general arthroscopic and orthopedic procedures
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.